{
    "organizations": [],
    "uuid": "b63b86a7a9e77712939c2cc7a652917651eb1bcf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-astrazenecas-ovarian-cancer-drug-l/brief-astrazenecas-ovarian-cancer-drug-lynparza-approved-in-japan-idUSFWN1PE01Q",
    "ord_in_thread": 0,
    "title": "BRIEF-AstraZeneca's ovarian cancer drug ‍Lynparza approved in Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 19 (Reuters) - Astrazeneca Plc:\n* ‍LYNPARZA RECEIVES APPROVAL IN JAPAN FOR TREATMENT OF ADVANCED OVARIAN CANCER​ Source text for Eikon: Further company coverage: (Reporting By London Bureau)\n ",
    "published": "2018-01-19T15:17:00.000+02:00",
    "crawled": "2018-01-20T17:35:15.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "astrazeneca",
        "plc",
        "receives",
        "approval",
        "japan",
        "treatment",
        "advanced",
        "ovarian",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "london",
        "bureau"
    ]
}